Literature DB >> 22100745

Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications.

Angela Burgess1, Luca Vanella, Lars Bellner, Michal L Schwartzman, Nader G Abraham.   

Abstract

MSCs are considered to be the natural precursors to adipocyte development through the process of adipogenesis. A link has been established between decreased protective effects of EETs or HO-1 and their interaction in metabolic syndrome. Decreases in HO-1 or EET were associated with an increase in adipocyte stem cell differentiation and increased levels of inflammatory cytokines. EET agonist (AKR-I-27-28) inhibited MSC-derived adipocytes and decreased the levels of inflammatory cytokines. We further describe the role of CYP-epoxygenase expression, HO expression, and circulating cytokine levels in an obese mouse, ob/ob(-/-) mouse model. Ex vivo measurements of EET expression within MSCs derived from ob/ob(-/-) showed decreased levels of EETs that were increased by HO induction. This review demonstrates that suppression of HO and EET systems exist in MSCs prior to the development of adipocyte dysfunction. Further, adipocyte dysfunction can be ameliorated by induction of HO-1 and CYP-epoxygenase, i.e. EET.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100745      PMCID: PMC3261364          DOI: 10.1016/j.prostaglandins.2011.10.002

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  154 in total

1.  Cytochrome P450-dependent arachidonic acid metabolism in human kidney.

Authors:  M L Schwartzman; P Martasek; A R Rios; R D Levere; K Solangi; A I Goodman; N G Abraham
Journal:  Kidney Int       Date:  1990-01       Impact factor: 10.612

Review 2.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

Review 3.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

4.  11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells.

Authors:  David Sacerdoti; Claudia Colombrita; Marco Di Pascoli; Michal L Schwartzman; Massimo Bolognesi; John R Falck; Angelo Gatta; Nader G Abraham
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-08-30       Impact factor: 3.072

5.  AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.

Authors:  Ingrid Fleming; Christian Schulz; Birgit Fichtlscherer; Bruce E Kemp; Beate Fisslthaler; Rudi Busse
Journal:  Thromb Haemost       Date:  2003-11       Impact factor: 5.249

6.  Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury.

Authors:  Leo E Otterbein; Brian S Zuckerbraun; Manabu Haga; Fang Liu; Ruiping Song; Anny Usheva; Christina Stachulak; Natalya Bodyak; R Neal Smith; Eva Csizmadia; Shivraj Tyagi; Yorihiro Akamatsu; Richard J Flavell; Timothy R Billiar; Edith Tzeng; Fritz H Bach; Augustine M K Choi; Miguel P Soares
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

Review 7.  Kidney CYP450 enzymes: biological actions beyond drug metabolism.

Authors:  X Zhao; J D Imig
Journal:  Curr Drug Metab       Date:  2003-02       Impact factor: 3.731

8.  Heme oxygenase in diabetes-induced oxidative stress in the heart.

Authors:  Hana Farhangkhoee; Zia A Khan; Suranjana Mukherjee; Mark Cukiernik; Yousef P Barbin; Morris Karmazyn; Subrata Chakrabarti
Journal:  J Mol Cell Cardiol       Date:  2003-12       Impact factor: 5.000

9.  Adipose tissue mass can be regulated through the vasculature.

Authors:  Maria A Rupnick; Dipak Panigrahy; Chen-Yu Zhang; Susan M Dallabrida; Bradford B Lowell; Robert Langer; M Judah Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

Review 10.  Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment (Review).

Authors:  S Ikehara
Journal:  Int J Mol Med       Date:  1998-01       Impact factor: 4.101

View more
  15 in total

Review 1.  The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.

Authors:  Xizhen Xu; Rui Li; Guangzhi Chen; Samantha L Hoopes; Darryl C Zeldin; Dao Wen Wang
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 2.  HO-1 overexpression and underexpression: Clinical implications.

Authors:  George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham
Journal:  Arch Biochem Biophys       Date:  2019-08-16       Impact factor: 4.013

Review 3.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

Review 4.  Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome.

Authors:  Nader G Abraham; Joshua M Junge; George S Drummond
Journal:  Trends Pharmacol Sci       Date:  2015-10-26       Impact factor: 14.819

5.  Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning.

Authors:  Xinyang Hu; Rongrong Wu; Zhi Jiang; Lihan Wang; Panpan Chen; Ling Zhang; Lu Yang; Yan Wu; Han Chen; Huiqiang Chen; Yinchuan Xu; Yu Zhou; Xin Huang; Keith A Webster; Hong Yu; Jian'an Wang
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

Review 6.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

7.  CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.

Authors:  Nader G Abraham; Komal Sodhi; Anne M Silvis; Luca Vanella; Gaia Favero; Rita Rezzani; Craig Lee; Darryl C Zeldin; Michal L Schwartzman
Journal:  Hypertension       Date:  2014-09-22       Impact factor: 10.190

8.  Inhibition of Soluble Epoxide Hydrolase 2 Ameliorates Diabetic Keratopathy and Impaired Wound Healing in Mouse Corneas.

Authors:  Haijing Sun; Patrick Lee; Chenxi Yan; Nan Gao; Jiemei Wang; Xianqun Fan; Fu-Shin Yu
Journal:  Diabetes       Date:  2018-04-03       Impact factor: 9.461

9.  Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial Function.

Authors:  Maayan Waldman; Lars Bellner; Luca Vanella; Joseph Schragenheim; Komal Sodhi; Shailendra P Singh; Daohong Lin; Anand Lakhkar; Jiangwei Li; Edith Hochhauser; Michael Arad; Zbigniew Darzynkiewicz; Atallah Kappas; Nader G Abraham
Journal:  Stem Cells Dev       Date:  2016-06-27       Impact factor: 3.272

10.  Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.

Authors:  Ahmed Bettaieb; Naoto Nagata; Daniel AbouBechara; Samah Chahed; Christophe Morisseau; Bruce D Hammock; Fawaz G Haj
Journal:  J Biol Chem       Date:  2013-04-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.